Jobs Roundtable Featuring Congressman Eric Cantor at Virginia Biotechnology Research Park and Tour of Health Diagnostic Laboratory, Inc.
October 19, 2011 —Richmond, Virginia— Health Diagnostic Laboratory, Inc. (HDL, Inc.), a CAP accredited leader in health management, will discuss innovation, entrepreneurship, and job creation at a Jobs Roundtable hosted by the Virginia Biotechnology Research Park, featuring Congressman Eric Cantor (VA-07), on Thursday, October 20th at 10:00am. Robert Skunda, CEO of Virginia Biotechnology Research Park, will lead the roundtable discussion that will include Congressman Eric Cantor and Tonya Mallory, President & CEO of HDL, Inc., along with other representatives of the Virginia Biotechnology Research Park and local businesses. The Jobs Roundtable will identify ways to spur economic growth.
WHO: Congressman Eric Cantor (VA-07)
WHAT: Participates in Jobs Roundtable & Tours Health Diagnostic Laboratory, Inc.
WHEN:
Thursday, October 20, 2011
10:00 AM – Roundtable
11:15 AM – Tour
WHERE:
Virginia Biotechnology Research Park
Biotech Center – Atrium
800 East Leigh Street
Richmond, VA
“Health Diagnostic Laboratory represents the spirit of the Virginia Life Science community and the culture of success that is vibrant throughout the Commonwealth at large,” said Mallory. “Our advanced lab, which is growing an average of five percent per week, is an example of the type of innovation, entrepreneurship, and job creation that is the backbone of our region.”
With its operations based in the Commonwealth of Virginia, Health Diagnostic Laboratory has hired over 350 employees, to arm more than 5,000 physicians with the tools to offer personalized treatment plans to their patients. The advanced laboratory has delivered over 6 million highly accurate and reproducible lab results since its creation two years ago, resulting in the medical community’s increased ability to both determine and monitor effective treatment for cardiovascular disease.
“Health Diagnostic Laboratory is saving millions of lives and healthcare dollars through advanced testing for cardiovascular and related diseases,” said Mallory. “The testing that our lab performs in Virginia provides early diagnosis of disease, which saves billions in healthcare expenses. More cost effective than other commonly used diagnostic options, diagnosis through lab testing helps reverse disease, save lives, and cut healthcare expenses dramatically.”
Following the roundtable, Congressman Cantor will hold brief press availability and then tour Health Diagnostic Laboratory, Inc, located in the Virginia Biotechnology Research Park.
About
Health Diagnostic Laboratory, Inc. (HDL, Inc.), a CAP accredited leader in health management, offers a comprehensive test menu of risk factors and biomarkers for cardiovascular and related diseases. Our systematic approach identifies factors contributing to disease and provides a basis for effective treatment, allowing physicians to more effectively manage patients. As an added value, patients receive a personalized overview of their risk factors along with intensive counseling from expert Health Coaches at no additional cost, improving compliance and enhancing satisfaction.
About the Virginia BioTechnology Research Park: The Virginia BioTechnology Research Park is currently home to a unique mix of over 60 public and private bioscience companies, research institutes affiliated with the VCU Medical Center, and major state and national medical laboratories. These companies are housed in nine buildings totaling more than 1.1 million square feet of space, representing an employee base that exceeds 2,000. The Park’s nationally recognized biosciences business incubation program, the Virginia Biosciences Development Center (VBDC), has successfully graduated more than 40 client companies, including three publicly traded firms. VBDC’s client companies and graduates have attracted more than $400 million in equity, grant and strategic capital. The Park’s Virginia Biosciences Commercialization Center was created to assist international life sciences companies locating at the Park with commercialization activities through M&A or IPO, giving these Park’s tenants full-scale business assistance as they enter the US market. The Commercialization Center is working with 12 bioscience companies with technologies ranging from medical devices to diagnostics and therapeutics. www.vabiotech.com
